nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNG3—hematopoietic system—hematologic cancer	0.0099	0.0395	CbGeAlD
Dalfampridine—KCNH1—hematopoietic system—hematologic cancer	0.0099	0.0395	CbGeAlD
Dalfampridine—KCNA10—lung—hematologic cancer	0.00892	0.0356	CbGeAlD
Dalfampridine—KCNG2—testis—hematologic cancer	0.00842	0.0336	CbGeAlD
Dalfampridine—KCNA3—hematopoietic system—hematologic cancer	0.00807	0.0322	CbGeAlD
Dalfampridine—KCNA2—hematopoietic system—hematologic cancer	0.00768	0.0306	CbGeAlD
Dalfampridine—KCNG3—blood—hematologic cancer	0.00656	0.0262	CbGeAlD
Dalfampridine—KCNH3—blood—hematologic cancer	0.00585	0.0233	CbGeAlD
Dalfampridine—KCNV2—testis—hematologic cancer	0.00569	0.0227	CbGeAlD
Dalfampridine—KCNH8—blood—hematologic cancer	0.00566	0.0226	CbGeAlD
Dalfampridine—KCND1—gonad—hematologic cancer	0.00558	0.0223	CbGeAlD
Dalfampridine—KCNH1—testis—hematologic cancer	0.00543	0.0216	CbGeAlD
Dalfampridine—KCNA3—blood—hematologic cancer	0.00535	0.0213	CbGeAlD
Dalfampridine—KCNA2—blood—hematologic cancer	0.00509	0.0203	CbGeAlD
Dalfampridine—KCNS1—blood—hematologic cancer	0.00509	0.0203	CbGeAlD
Dalfampridine—KCND1—blood—hematologic cancer	0.00486	0.0194	CbGeAlD
Dalfampridine—KCNH3—testis—hematologic cancer	0.00484	0.0193	CbGeAlD
Dalfampridine—KCNG1—testis—hematologic cancer	0.00484	0.0193	CbGeAlD
Dalfampridine—KCNA3—lung—hematologic cancer	0.00469	0.0187	CbGeAlD
Dalfampridine—KCNH8—testis—hematologic cancer	0.00468	0.0187	CbGeAlD
Dalfampridine—KCNC3—testis—hematologic cancer	0.00455	0.0181	CbGeAlD
Dalfampridine—KCNA5—gonad—hematologic cancer	0.00428	0.0171	CbGeAlD
Dalfampridine—KCND1—lung—hematologic cancer	0.00426	0.017	CbGeAlD
Dalfampridine—KCNC4—lung—hematologic cancer	0.00426	0.017	CbGeAlD
Dalfampridine—KCNS1—testis—hematologic cancer	0.00421	0.0168	CbGeAlD
Dalfampridine—KCNA2—testis—hematologic cancer	0.00421	0.0168	CbGeAlD
Dalfampridine—KCNF1—blood—hematologic cancer	0.00417	0.0166	CbGeAlD
Dalfampridine—KCNC4—testis—hematologic cancer	0.00402	0.016	CbGeAlD
Dalfampridine—KCND1—testis—hematologic cancer	0.00402	0.016	CbGeAlD
Dalfampridine—KCNC1—testis—hematologic cancer	0.00387	0.0154	CbGeAlD
Dalfampridine—KCNH7—testis—hematologic cancer	0.00387	0.0154	CbGeAlD
Dalfampridine—KCNQ4—testis—hematologic cancer	0.00387	0.0154	CbGeAlD
Dalfampridine—KCNQ2—gonad—hematologic cancer	0.00385	0.0154	CbGeAlD
Dalfampridine—KCNF1—lung—hematologic cancer	0.00365	0.0146	CbGeAlD
Dalfampridine—KCNA5—lung—hematologic cancer	0.00327	0.013	CbGeAlD
Dalfampridine—KCNA3—lymph node—hematologic cancer	0.00321	0.0128	CbGeAlD
Dalfampridine—KCNS3—lung—hematologic cancer	0.0032	0.0128	CbGeAlD
Dalfampridine—KCNQ3—lung—hematologic cancer	0.0032	0.0128	CbGeAlD
Dalfampridine—KCNA5—testis—hematologic cancer	0.00308	0.0123	CbGeAlD
Dalfampridine—KCNA2—lymph node—hematologic cancer	0.00305	0.0122	CbGeAlD
Dalfampridine—KCNS3—testis—hematologic cancer	0.00302	0.012	CbGeAlD
Dalfampridine—KCNH6—lung—hematologic cancer	0.00292	0.0116	CbGeAlD
Dalfampridine—KCNC4—lymph node—hematologic cancer	0.00292	0.0116	CbGeAlD
Dalfampridine—KCNQ2—testis—hematologic cancer	0.00278	0.0111	CbGeAlD
Dalfampridine—KCNQ5—lymph node—hematologic cancer	0.00273	0.0109	CbGeAlD
Dalfampridine—KCNQ1—blood—hematologic cancer	0.00268	0.0107	CbGeAlD
Dalfampridine—KCND2—testis—hematologic cancer	0.00263	0.0105	CbGeAlD
Dalfampridine—KCNQ1—bone marrow—hematologic cancer	0.0026	0.0104	CbGeAlD
Dalfampridine—KCND3—lung—hematologic cancer	0.00243	0.00969	CbGeAlD
Dalfampridine—KCNQ1—lung—hematologic cancer	0.00235	0.00938	CbGeAlD
Dalfampridine—KCND3—testis—hematologic cancer	0.00229	0.00914	CbGeAlD
Dalfampridine—KCNA5—lymph node—hematologic cancer	0.00223	0.00891	CbGeAlD
Dalfampridine—KCNQ1—testis—hematologic cancer	0.00222	0.00885	CbGeAlD
Dalfampridine—KCNS3—lymph node—hematologic cancer	0.00219	0.00872	CbGeAlD
Dalfampridine—KCND3—lymph node—hematologic cancer	0.00166	0.00663	CbGeAlD
Dalfampridine—KCNQ1—lymph node—hematologic cancer	0.00161	0.00642	CbGeAlD
Dalfampridine—KCNH2—hematopoietic system—hematologic cancer	0.00154	0.00616	CbGeAlD
Dalfampridine—CYP2E1—hematopoietic system—hematologic cancer	0.00119	0.00474	CbGeAlD
Dalfampridine—KCNH2—blood—hematologic cancer	0.00102	0.00408	CbGeAlD
Dalfampridine—KCNH2—bone marrow—hematologic cancer	0.00099	0.00395	CbGeAlD
Dalfampridine—KCNH2—testis—hematologic cancer	0.000846	0.00338	CbGeAlD
Dalfampridine—CYP2E1—blood—hematologic cancer	0.000788	0.00314	CbGeAlD
Dalfampridine—CYP2E1—lung—hematologic cancer	0.000691	0.00276	CbGeAlD
Dalfampridine—CYP2E1—testis—hematologic cancer	0.000652	0.0026	CbGeAlD
Dalfampridine—KCNH2—lymph node—hematologic cancer	0.000614	0.00245	CbGeAlD
Dalfampridine—Infestation—Epirubicin—hematologic cancer	0.000252	0.000495	CcSEcCtD
Dalfampridine—Rash—Thiotepa—hematologic cancer	0.000252	0.000494	CcSEcCtD
Dalfampridine—Dermatitis—Thiotepa—hematologic cancer	0.000252	0.000494	CcSEcCtD
Dalfampridine—Convulsion—Dexamethasone—hematologic cancer	0.000251	0.000492	CcSEcCtD
Dalfampridine—Convulsion—Betamethasone—hematologic cancer	0.000251	0.000492	CcSEcCtD
Dalfampridine—Headache—Thiotepa—hematologic cancer	0.00025	0.000491	CcSEcCtD
Dalfampridine—Nausea—Vinorelbine—hematologic cancer	0.000248	0.000487	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Etoposide—hematologic cancer	0.000248	0.000486	CcSEcCtD
Dalfampridine—Asthenia—Mitoxantrone—hematologic cancer	0.000247	0.000486	CcSEcCtD
Dalfampridine—Asthenia—Irinotecan—hematologic cancer	0.000247	0.000486	CcSEcCtD
Dalfampridine—Vomiting—Thalidomide—hematologic cancer	0.000246	0.000482	CcSEcCtD
Dalfampridine—Anxiety—Betamethasone—hematologic cancer	0.000245	0.000482	CcSEcCtD
Dalfampridine—Anxiety—Dexamethasone—hematologic cancer	0.000245	0.000482	CcSEcCtD
Dalfampridine—Dizziness—Carmustine—hematologic cancer	0.000245	0.000481	CcSEcCtD
Dalfampridine—Constipation—Etoposide—hematologic cancer	0.000245	0.000481	CcSEcCtD
Dalfampridine—Urinary tract infection—Epirubicin—hematologic cancer	0.000245	0.000481	CcSEcCtD
Dalfampridine—Rash—Thalidomide—hematologic cancer	0.000244	0.000478	CcSEcCtD
Dalfampridine—Dermatitis—Thalidomide—hematologic cancer	0.000243	0.000478	CcSEcCtD
Dalfampridine—Dizziness—Alitretinoin—hematologic cancer	0.000243	0.000477	CcSEcCtD
Dalfampridine—Headache—Thalidomide—hematologic cancer	0.000242	0.000475	CcSEcCtD
Dalfampridine—Asthenia—Gemcitabine—hematologic cancer	0.000241	0.000473	CcSEcCtD
Dalfampridine—Dizziness—Ifosfamide—hematologic cancer	0.00024	0.000471	CcSEcCtD
Dalfampridine—Nausea—Thiotepa—hematologic cancer	0.000237	0.000466	CcSEcCtD
Dalfampridine—Feeling abnormal—Etoposide—hematologic cancer	0.000236	0.000464	CcSEcCtD
Dalfampridine—Anaphylactic shock—Betamethasone—hematologic cancer	0.000236	0.000463	CcSEcCtD
Dalfampridine—Anaphylactic shock—Dexamethasone—hematologic cancer	0.000236	0.000463	CcSEcCtD
Dalfampridine—Vomiting—Carmustine—hematologic cancer	0.000236	0.000463	CcSEcCtD
Dalfampridine—Insomnia—Triamcinolone—hematologic cancer	0.000235	0.000462	CcSEcCtD
Dalfampridine—Infection—Dexamethasone—hematologic cancer	0.000235	0.00046	CcSEcCtD
Dalfampridine—Infection—Betamethasone—hematologic cancer	0.000235	0.00046	CcSEcCtD
Dalfampridine—Dizziness—Vincristine—hematologic cancer	0.000234	0.00046	CcSEcCtD
Dalfampridine—Rash—Carmustine—hematologic cancer	0.000234	0.000459	CcSEcCtD
Dalfampridine—Dermatitis—Carmustine—hematologic cancer	0.000234	0.000459	CcSEcCtD
Dalfampridine—Vomiting—Alitretinoin—hematologic cancer	0.000234	0.000459	CcSEcCtD
Dalfampridine—Paraesthesia—Triamcinolone—hematologic cancer	0.000234	0.000459	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—hematologic cancer	0.000233	0.000458	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—hematologic cancer	0.000233	0.000458	CcSEcCtD
Dalfampridine—Feeling abnormal—Prednisolone—hematologic cancer	0.000233	0.000458	CcSEcCtD
Dalfampridine—Headache—Carmustine—hematologic cancer	0.000232	0.000456	CcSEcCtD
Dalfampridine—Dyspnoea—Triamcinolone—hematologic cancer	0.000232	0.000455	CcSEcCtD
Dalfampridine—Rash—Alitretinoin—hematologic cancer	0.000232	0.000455	CcSEcCtD
Dalfampridine—Nervous system disorder—Dexamethasone—hematologic cancer	0.000232	0.000454	CcSEcCtD
Dalfampridine—Nervous system disorder—Betamethasone—hematologic cancer	0.000232	0.000454	CcSEcCtD
Dalfampridine—Dermatitis—Alitretinoin—hematologic cancer	0.000231	0.000454	CcSEcCtD
Dalfampridine—Vomiting—Ifosfamide—hematologic cancer	0.000231	0.000453	CcSEcCtD
Dalfampridine—Hypersensitivity—Cisplatin—hematologic cancer	0.000231	0.000453	CcSEcCtD
Dalfampridine—Headache—Alitretinoin—hematologic cancer	0.00023	0.000452	CcSEcCtD
Dalfampridine—Angioedema—Prednisone—hematologic cancer	0.00023	0.000452	CcSEcCtD
Dalfampridine—Nausea—Thalidomide—hematologic cancer	0.000229	0.00045	CcSEcCtD
Dalfampridine—Dyspepsia—Triamcinolone—hematologic cancer	0.000229	0.00045	CcSEcCtD
Dalfampridine—Rash—Ifosfamide—hematologic cancer	0.000229	0.000449	CcSEcCtD
Dalfampridine—Dermatitis—Ifosfamide—hematologic cancer	0.000229	0.000449	CcSEcCtD
Dalfampridine—Dizziness—Irinotecan—hematologic cancer	0.000228	0.000448	CcSEcCtD
Dalfampridine—Urticaria—Etoposide—hematologic cancer	0.000228	0.000447	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—hematologic cancer	0.000227	0.000445	CcSEcCtD
Dalfampridine—Vomiting—Vincristine—hematologic cancer	0.000225	0.000442	CcSEcCtD
Dalfampridine—Urticaria—Prednisolone—hematologic cancer	0.000225	0.000441	CcSEcCtD
Dalfampridine—Asthenia—Cisplatin—hematologic cancer	0.000225	0.000441	CcSEcCtD
Dalfampridine—Rash—Vincristine—hematologic cancer	0.000223	0.000438	CcSEcCtD
Dalfampridine—Dermatitis—Vincristine—hematologic cancer	0.000223	0.000438	CcSEcCtD
Dalfampridine—Connective tissue disorder—Epirubicin—hematologic cancer	0.000222	0.000437	CcSEcCtD
Dalfampridine—Headache—Vincristine—hematologic cancer	0.000222	0.000435	CcSEcCtD
Dalfampridine—Hypotension—Dexamethasone—hematologic cancer	0.000221	0.000433	CcSEcCtD
Dalfampridine—Hypotension—Betamethasone—hematologic cancer	0.000221	0.000433	CcSEcCtD
Dalfampridine—Nausea—Carmustine—hematologic cancer	0.00022	0.000432	CcSEcCtD
Dalfampridine—Angiopathy—Methotrexate—hematologic cancer	0.000219	0.000431	CcSEcCtD
Dalfampridine—Vomiting—Mitoxantrone—hematologic cancer	0.000219	0.00043	CcSEcCtD
Dalfampridine—Vomiting—Irinotecan—hematologic cancer	0.000219	0.00043	CcSEcCtD
Dalfampridine—Immune system disorder—Methotrexate—hematologic cancer	0.000218	0.000429	CcSEcCtD
Dalfampridine—Nausea—Alitretinoin—hematologic cancer	0.000218	0.000428	CcSEcCtD
Dalfampridine—Convulsion—Prednisone—hematologic cancer	0.000218	0.000428	CcSEcCtD
Dalfampridine—Mediastinal disorder—Methotrexate—hematologic cancer	0.000218	0.000428	CcSEcCtD
Dalfampridine—Rash—Mitoxantrone—hematologic cancer	0.000217	0.000427	CcSEcCtD
Dalfampridine—Rash—Irinotecan—hematologic cancer	0.000217	0.000427	CcSEcCtD
Dalfampridine—Dermatitis—Mitoxantrone—hematologic cancer	0.000217	0.000426	CcSEcCtD
Dalfampridine—Dermatitis—Irinotecan—hematologic cancer	0.000217	0.000426	CcSEcCtD
Dalfampridine—Headache—Irinotecan—hematologic cancer	0.000216	0.000424	CcSEcCtD
Dalfampridine—Headache—Mitoxantrone—hematologic cancer	0.000216	0.000424	CcSEcCtD
Dalfampridine—Nausea—Ifosfamide—hematologic cancer	0.000216	0.000423	CcSEcCtD
Dalfampridine—Feeling abnormal—Triamcinolone—hematologic cancer	0.000214	0.000421	CcSEcCtD
Dalfampridine—Anxiety—Prednisone—hematologic cancer	0.000214	0.000419	CcSEcCtD
Dalfampridine—Vomiting—Gemcitabine—hematologic cancer	0.000214	0.000419	CcSEcCtD
Dalfampridine—Insomnia—Dexamethasone—hematologic cancer	0.000214	0.000419	CcSEcCtD
Dalfampridine—Insomnia—Betamethasone—hematologic cancer	0.000214	0.000419	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	0.000213	0.000418	CcSEcCtD
Dalfampridine—Paraesthesia—Betamethasone—hematologic cancer	0.000212	0.000416	CcSEcCtD
Dalfampridine—Paraesthesia—Dexamethasone—hematologic cancer	0.000212	0.000416	CcSEcCtD
Dalfampridine—Mental disorder—Methotrexate—hematologic cancer	0.000212	0.000416	CcSEcCtD
Dalfampridine—Rash—Gemcitabine—hematologic cancer	0.000212	0.000416	CcSEcCtD
Dalfampridine—Dermatitis—Gemcitabine—hematologic cancer	0.000212	0.000415	CcSEcCtD
Dalfampridine—Hypersensitivity—Etoposide—hematologic cancer	0.000211	0.000415	CcSEcCtD
Dalfampridine—Headache—Gemcitabine—hematologic cancer	0.00021	0.000413	CcSEcCtD
Dalfampridine—Nausea—Vincristine—hematologic cancer	0.00021	0.000413	CcSEcCtD
Dalfampridine—Hypersensitivity—Prednisolone—hematologic cancer	0.000208	0.000409	CcSEcCtD
Dalfampridine—Dyspepsia—Dexamethasone—hematologic cancer	0.000208	0.000408	CcSEcCtD
Dalfampridine—Dyspepsia—Betamethasone—hematologic cancer	0.000208	0.000408	CcSEcCtD
Dalfampridine—Urticaria—Triamcinolone—hematologic cancer	0.000207	0.000406	CcSEcCtD
Dalfampridine—Asthenia—Etoposide—hematologic cancer	0.000206	0.000404	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—hematologic cancer	0.000206	0.000404	CcSEcCtD
Dalfampridine—Anaphylactic shock—Prednisone—hematologic cancer	0.000206	0.000404	CcSEcCtD
Dalfampridine—Angiopathy—Epirubicin—hematologic cancer	0.000205	0.000403	CcSEcCtD
Dalfampridine—Nausea—Mitoxantrone—hematologic cancer	0.000205	0.000402	CcSEcCtD
Dalfampridine—Nausea—Irinotecan—hematologic cancer	0.000205	0.000402	CcSEcCtD
Dalfampridine—Immune system disorder—Epirubicin—hematologic cancer	0.000204	0.000401	CcSEcCtD
Dalfampridine—Infection—Prednisone—hematologic cancer	0.000204	0.000401	CcSEcCtD
Dalfampridine—Mediastinal disorder—Epirubicin—hematologic cancer	0.000204	0.0004	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000204	0.0004	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000204	0.0004	CcSEcCtD
Dalfampridine—Back pain—Methotrexate—hematologic cancer	0.000204	0.0004	CcSEcCtD
Dalfampridine—Nervous system disorder—Prednisone—hematologic cancer	0.000202	0.000396	CcSEcCtD
Dalfampridine—Skin disorder—Prednisone—hematologic cancer	0.0002	0.000392	CcSEcCtD
Dalfampridine—Nausea—Gemcitabine—hematologic cancer	0.0002	0.000392	CcSEcCtD
Dalfampridine—Vomiting—Cisplatin—hematologic cancer	0.000199	0.000391	CcSEcCtD
Dalfampridine—Mental disorder—Epirubicin—hematologic cancer	0.000198	0.000389	CcSEcCtD
Dalfampridine—Rash—Cisplatin—hematologic cancer	0.000197	0.000387	CcSEcCtD
Dalfampridine—Dermatitis—Cisplatin—hematologic cancer	0.000197	0.000387	CcSEcCtD
Dalfampridine—Feeling abnormal—Betamethasone—hematologic cancer	0.000195	0.000382	CcSEcCtD
Dalfampridine—Feeling abnormal—Dexamethasone—hematologic cancer	0.000195	0.000382	CcSEcCtD
Dalfampridine—Hypersensitivity—Triamcinolone—hematologic cancer	0.000192	0.000376	CcSEcCtD
Dalfampridine—Back pain—Epirubicin—hematologic cancer	0.000191	0.000374	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—hematologic cancer	0.00019	0.000373	CcSEcCtD
Dalfampridine—Dizziness—Etoposide—hematologic cancer	0.00019	0.000372	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—hematologic cancer	0.000189	0.000371	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—hematologic cancer	0.000189	0.00037	CcSEcCtD
Dalfampridine—Urticaria—Dexamethasone—hematologic cancer	0.000188	0.000368	CcSEcCtD
Dalfampridine—Urticaria—Betamethasone—hematologic cancer	0.000188	0.000368	CcSEcCtD
Dalfampridine—Dizziness—Prednisolone—hematologic cancer	0.000187	0.000367	CcSEcCtD
Dalfampridine—Asthenia—Triamcinolone—hematologic cancer	0.000187	0.000366	CcSEcCtD
Dalfampridine—Nausea—Cisplatin—hematologic cancer	0.000186	0.000365	CcSEcCtD
Dalfampridine—Insomnia—Prednisone—hematologic cancer	0.000186	0.000365	CcSEcCtD
Dalfampridine—Paraesthesia—Prednisone—hematologic cancer	0.000185	0.000362	CcSEcCtD
Dalfampridine—Mental disorder—Doxorubicin—hematologic cancer	0.000183	0.00036	CcSEcCtD
Dalfampridine—Convulsion—Methotrexate—hematologic cancer	0.000182	0.000358	CcSEcCtD
Dalfampridine—Vomiting—Etoposide—hematologic cancer	0.000182	0.000358	CcSEcCtD
Dalfampridine—Dyspepsia—Prednisone—hematologic cancer	0.000181	0.000355	CcSEcCtD
Dalfampridine—Rash—Etoposide—hematologic cancer	0.000181	0.000355	CcSEcCtD
Dalfampridine—Dermatitis—Etoposide—hematologic cancer	0.000181	0.000355	CcSEcCtD
Dalfampridine—Headache—Etoposide—hematologic cancer	0.00018	0.000353	CcSEcCtD
Dalfampridine—Chest pain—Methotrexate—hematologic cancer	0.000179	0.000352	CcSEcCtD
Dalfampridine—Rash—Prednisolone—hematologic cancer	0.000178	0.00035	CcSEcCtD
Dalfampridine—Dermatitis—Prednisolone—hematologic cancer	0.000178	0.00035	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000178	0.000349	CcSEcCtD
Dalfampridine—Headache—Prednisolone—hematologic cancer	0.000177	0.000348	CcSEcCtD
Dalfampridine—Back pain—Doxorubicin—hematologic cancer	0.000176	0.000346	CcSEcCtD
Dalfampridine—Constipation—Prednisone—hematologic cancer	0.000176	0.000345	CcSEcCtD
Dalfampridine—Confusional state—Methotrexate—hematologic cancer	0.000173	0.00034	CcSEcCtD
Dalfampridine—Dizziness—Triamcinolone—hematologic cancer	0.000172	0.000338	CcSEcCtD
Dalfampridine—Anaphylactic shock—Methotrexate—hematologic cancer	0.000172	0.000337	CcSEcCtD
Dalfampridine—Convulsion—Epirubicin—hematologic cancer	0.000171	0.000335	CcSEcCtD
Dalfampridine—Infection—Methotrexate—hematologic cancer	0.000171	0.000335	CcSEcCtD
Dalfampridine—Nausea—Etoposide—hematologic cancer	0.00017	0.000334	CcSEcCtD
Dalfampridine—Feeling abnormal—Prednisone—hematologic cancer	0.000169	0.000333	CcSEcCtD
Dalfampridine—Asthenia—Dexamethasone—hematologic cancer	0.000169	0.000332	CcSEcCtD
Dalfampridine—Asthenia—Betamethasone—hematologic cancer	0.000169	0.000332	CcSEcCtD
Dalfampridine—Nervous system disorder—Methotrexate—hematologic cancer	0.000168	0.000331	CcSEcCtD
Dalfampridine—Nausea—Prednisolone—hematologic cancer	0.000168	0.00033	CcSEcCtD
Dalfampridine—Chest pain—Epirubicin—hematologic cancer	0.000168	0.000329	CcSEcCtD
Dalfampridine—Anxiety—Epirubicin—hematologic cancer	0.000167	0.000328	CcSEcCtD
Dalfampridine—Skin disorder—Methotrexate—hematologic cancer	0.000167	0.000328	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000167	0.000327	CcSEcCtD
Dalfampridine—Vomiting—Triamcinolone—hematologic cancer	0.000165	0.000325	CcSEcCtD
Dalfampridine—Rash—Triamcinolone—hematologic cancer	0.000164	0.000322	CcSEcCtD
Dalfampridine—Dermatitis—Triamcinolone—hematologic cancer	0.000164	0.000322	CcSEcCtD
Dalfampridine—Urticaria—Prednisone—hematologic cancer	0.000163	0.000321	CcSEcCtD
Dalfampridine—Headache—Triamcinolone—hematologic cancer	0.000163	0.00032	CcSEcCtD
Dalfampridine—Confusional state—Epirubicin—hematologic cancer	0.000162	0.000318	CcSEcCtD
Dalfampridine—Anaphylactic shock—Epirubicin—hematologic cancer	0.000161	0.000316	CcSEcCtD
Dalfampridine—Hypotension—Methotrexate—hematologic cancer	0.000161	0.000315	CcSEcCtD
Dalfampridine—Infection—Epirubicin—hematologic cancer	0.00016	0.000314	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—hematologic cancer	0.000158	0.00031	CcSEcCtD
Dalfampridine—Nervous system disorder—Epirubicin—hematologic cancer	0.000158	0.000309	CcSEcCtD
Dalfampridine—Skin disorder—Epirubicin—hematologic cancer	0.000156	0.000307	CcSEcCtD
Dalfampridine—Dizziness—Dexamethasone—hematologic cancer	0.000156	0.000306	CcSEcCtD
Dalfampridine—Dizziness—Betamethasone—hematologic cancer	0.000156	0.000306	CcSEcCtD
Dalfampridine—Insomnia—Methotrexate—hematologic cancer	0.000155	0.000305	CcSEcCtD
Dalfampridine—Chest pain—Doxorubicin—hematologic cancer	0.000155	0.000305	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—hematologic cancer	0.000155	0.000304	CcSEcCtD
Dalfampridine—Nausea—Triamcinolone—hematologic cancer	0.000155	0.000303	CcSEcCtD
Dalfampridine—Paraesthesia—Methotrexate—hematologic cancer	0.000154	0.000303	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	0.000154	0.000303	CcSEcCtD
Dalfampridine—Dyspnoea—Methotrexate—hematologic cancer	0.000153	0.000301	CcSEcCtD
Dalfampridine—Hypersensitivity—Prednisone—hematologic cancer	0.000151	0.000297	CcSEcCtD
Dalfampridine—Dyspepsia—Methotrexate—hematologic cancer	0.000151	0.000297	CcSEcCtD
Dalfampridine—Hypotension—Epirubicin—hematologic cancer	0.00015	0.000295	CcSEcCtD
Dalfampridine—Vomiting—Dexamethasone—hematologic cancer	0.00015	0.000295	CcSEcCtD
Dalfampridine—Vomiting—Betamethasone—hematologic cancer	0.00015	0.000295	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—hematologic cancer	0.00015	0.000294	CcSEcCtD
Dalfampridine—Rash—Betamethasone—hematologic cancer	0.000149	0.000292	CcSEcCtD
Dalfampridine—Rash—Dexamethasone—hematologic cancer	0.000149	0.000292	CcSEcCtD
Dalfampridine—Anaphylactic shock—Doxorubicin—hematologic cancer	0.000149	0.000292	CcSEcCtD
Dalfampridine—Dermatitis—Dexamethasone—hematologic cancer	0.000149	0.000292	CcSEcCtD
Dalfampridine—Dermatitis—Betamethasone—hematologic cancer	0.000149	0.000292	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000148	0.000291	CcSEcCtD
Dalfampridine—Headache—Dexamethasone—hematologic cancer	0.000148	0.00029	CcSEcCtD
Dalfampridine—Headache—Betamethasone—hematologic cancer	0.000148	0.00029	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—hematologic cancer	0.000148	0.00029	CcSEcCtD
Dalfampridine—Asthenia—Prednisone—hematologic cancer	0.000148	0.00029	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—hematologic cancer	0.000146	0.000286	CcSEcCtD
Dalfampridine—Insomnia—Epirubicin—hematologic cancer	0.000145	0.000285	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—hematologic cancer	0.000145	0.000284	CcSEcCtD
Dalfampridine—Paraesthesia—Epirubicin—hematologic cancer	0.000144	0.000283	CcSEcCtD
Dalfampridine—Dyspnoea—Epirubicin—hematologic cancer	0.000143	0.000281	CcSEcCtD
Dalfampridine—Feeling abnormal—Methotrexate—hematologic cancer	0.000142	0.000278	CcSEcCtD
Dalfampridine—Dyspepsia—Epirubicin—hematologic cancer	0.000142	0.000278	CcSEcCtD
Dalfampridine—Nausea—Betamethasone—hematologic cancer	0.00014	0.000275	CcSEcCtD
Dalfampridine—Nausea—Dexamethasone—hematologic cancer	0.00014	0.000275	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—hematologic cancer	0.000139	0.000273	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Epirubicin—hematologic cancer	0.000139	0.000272	CcSEcCtD
Dalfampridine—Constipation—Epirubicin—hematologic cancer	0.000137	0.00027	CcSEcCtD
Dalfampridine—Urticaria—Methotrexate—hematologic cancer	0.000136	0.000268	CcSEcCtD
Dalfampridine—Dizziness—Prednisone—hematologic cancer	0.000136	0.000267	CcSEcCtD
Dalfampridine—Insomnia—Doxorubicin—hematologic cancer	0.000135	0.000264	CcSEcCtD
Dalfampridine—Paraesthesia—Doxorubicin—hematologic cancer	0.000134	0.000262	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—hematologic cancer	0.000133	0.00026	CcSEcCtD
Dalfampridine—Feeling abnormal—Epirubicin—hematologic cancer	0.000132	0.00026	CcSEcCtD
Dalfampridine—Dyspepsia—Doxorubicin—hematologic cancer	0.000131	0.000257	CcSEcCtD
Dalfampridine—Vomiting—Prednisone—hematologic cancer	0.000131	0.000257	CcSEcCtD
Dalfampridine—Rash—Prednisone—hematologic cancer	0.00013	0.000254	CcSEcCtD
Dalfampridine—Dermatitis—Prednisone—hematologic cancer	0.00013	0.000254	CcSEcCtD
Dalfampridine—Headache—Prednisone—hematologic cancer	0.000129	0.000253	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	0.000128	0.000252	CcSEcCtD
Dalfampridine—Urticaria—Epirubicin—hematologic cancer	0.000128	0.000251	CcSEcCtD
Dalfampridine—Constipation—Doxorubicin—hematologic cancer	0.000127	0.00025	CcSEcCtD
Dalfampridine—Hypersensitivity—Methotrexate—hematologic cancer	0.000127	0.000248	CcSEcCtD
Dalfampridine—Asthenia—Methotrexate—hematologic cancer	0.000123	0.000242	CcSEcCtD
Dalfampridine—Feeling abnormal—Doxorubicin—hematologic cancer	0.000123	0.000241	CcSEcCtD
Dalfampridine—Nausea—Prednisone—hematologic cancer	0.000122	0.00024	CcSEcCtD
Dalfampridine—Hypersensitivity—Epirubicin—hematologic cancer	0.000118	0.000233	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—hematologic cancer	0.000118	0.000232	CcSEcCtD
Dalfampridine—Asthenia—Epirubicin—hematologic cancer	0.000115	0.000226	CcSEcCtD
Dalfampridine—Dizziness—Methotrexate—hematologic cancer	0.000114	0.000223	CcSEcCtD
Dalfampridine—Hypersensitivity—Doxorubicin—hematologic cancer	0.00011	0.000215	CcSEcCtD
Dalfampridine—Vomiting—Methotrexate—hematologic cancer	0.000109	0.000214	CcSEcCtD
Dalfampridine—Rash—Methotrexate—hematologic cancer	0.000108	0.000213	CcSEcCtD
Dalfampridine—Dermatitis—Methotrexate—hematologic cancer	0.000108	0.000212	CcSEcCtD
Dalfampridine—Headache—Methotrexate—hematologic cancer	0.000108	0.000211	CcSEcCtD
Dalfampridine—Asthenia—Doxorubicin—hematologic cancer	0.000107	0.00021	CcSEcCtD
Dalfampridine—Dizziness—Epirubicin—hematologic cancer	0.000106	0.000209	CcSEcCtD
Dalfampridine—Vomiting—Epirubicin—hematologic cancer	0.000102	0.000201	CcSEcCtD
Dalfampridine—Nausea—Methotrexate—hematologic cancer	0.000102	0.0002	CcSEcCtD
Dalfampridine—Rash—Epirubicin—hematologic cancer	0.000101	0.000199	CcSEcCtD
Dalfampridine—Dermatitis—Epirubicin—hematologic cancer	0.000101	0.000199	CcSEcCtD
Dalfampridine—Headache—Epirubicin—hematologic cancer	0.000101	0.000198	CcSEcCtD
Dalfampridine—Dizziness—Doxorubicin—hematologic cancer	9.84e-05	0.000193	CcSEcCtD
Dalfampridine—Nausea—Epirubicin—hematologic cancer	9.55e-05	0.000187	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—hematologic cancer	9.46e-05	0.000186	CcSEcCtD
Dalfampridine—Rash—Doxorubicin—hematologic cancer	9.38e-05	0.000184	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—hematologic cancer	9.37e-05	0.000184	CcSEcCtD
Dalfampridine—Headache—Doxorubicin—hematologic cancer	9.32e-05	0.000183	CcSEcCtD
Dalfampridine—Nausea—Doxorubicin—hematologic cancer	8.84e-05	0.000173	CcSEcCtD
Dalfampridine—KCNB1—Metabolism—ABCG2—hematologic cancer	8.57e-05	0.000357	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MTR—hematologic cancer	8.57e-05	0.000357	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—JAK1—hematologic cancer	8.47e-05	0.000353	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—JAK1—hematologic cancer	8.47e-05	0.000353	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ENO2—hematologic cancer	8.4e-05	0.00035	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SDC1—hematologic cancer	8.4e-05	0.00035	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SDC1—hematologic cancer	8.4e-05	0.00035	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—SDC1—hematologic cancer	8.4e-05	0.00035	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—HRAS—hematologic cancer	8.33e-05	0.000347	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—HRAS—hematologic cancer	8.33e-05	0.000347	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—TP53—hematologic cancer	8.22e-05	0.000343	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—MDM2—hematologic cancer	8.19e-05	0.000342	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—MDM2—hematologic cancer	8.19e-05	0.000342	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAP2K1—hematologic cancer	8.17e-05	0.000341	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAP2K1—hematologic cancer	8.17e-05	0.000341	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTT1—hematologic cancer	8.15e-05	0.00034	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—SDC1—hematologic cancer	7.96e-05	0.000332	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CREB1—hematologic cancer	7.85e-05	0.000327	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—MDM2—hematologic cancer	7.81e-05	0.000326	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—MTR—hematologic cancer	7.68e-05	0.00032	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6R—hematologic cancer	7.66e-05	0.000319	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CREBBP—hematologic cancer	7.65e-05	0.000319	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—IL6—hematologic cancer	7.53e-05	0.000314	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—JAK2—hematologic cancer	7.45e-05	0.000311	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—JAK2—hematologic cancer	7.45e-05	0.000311	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTT1—hematologic cancer	7.3e-05	0.000305	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—hematologic cancer	7.19e-05	0.0003	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NQO1—hematologic cancer	7.14e-05	0.000298	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CD44—hematologic cancer	7.14e-05	0.000298	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NQO1—hematologic cancer	7.14e-05	0.000298	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CD44—hematologic cancer	7.14e-05	0.000298	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CD44—hematologic cancer	7.14e-05	0.000298	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NQO1—hematologic cancer	7.14e-05	0.000298	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK14—hematologic cancer	7.1e-05	0.000296	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK14—hematologic cancer	7.1e-05	0.000296	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CDK4—hematologic cancer	7e-05	0.000292	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MET—hematologic cancer	7e-05	0.000292	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CDK4—hematologic cancer	7e-05	0.000292	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MET—hematologic cancer	7e-05	0.000292	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—HRAS—hematologic cancer	6.98e-05	0.000291	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—HRAS—hematologic cancer	6.98e-05	0.000291	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—HRAS—hematologic cancer	6.98e-05	0.000291	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—HRAS—hematologic cancer	6.79e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CD44—hematologic cancer	6.77e-05	0.000282	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NQO1—hematologic cancer	6.77e-05	0.000282	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYCS—hematologic cancer	6.76e-05	0.000282	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYCS—hematologic cancer	6.76e-05	0.000282	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYCS—hematologic cancer	6.76e-05	0.000282	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NOTCH1—hematologic cancer	6.74e-05	0.000281	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NOTCH1—hematologic cancer	6.74e-05	0.000281	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—HSP90AA1—hematologic cancer	6.72e-05	0.00028	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—HSP90AA1—hematologic cancer	6.72e-05	0.00028	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—HSP90AA1—hematologic cancer	6.72e-05	0.00028	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—PRKCG—hematologic cancer	6.66e-05	0.000278	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—HRAS—hematologic cancer	6.61e-05	0.000276	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—IL6—hematologic cancer	6.58e-05	0.000274	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PTPN11—hematologic cancer	6.47e-05	0.00027	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PTPN11—hematologic cancer	6.47e-05	0.00027	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYCS—hematologic cancer	6.41e-05	0.000267	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—HSP90AA1—hematologic cancer	6.37e-05	0.000266	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CREB1—hematologic cancer	6.27e-05	0.000262	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CREB1—hematologic cancer	6.27e-05	0.000262	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6R—hematologic cancer	6.12e-05	0.000255	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6R—hematologic cancer	6.12e-05	0.000255	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CREBBP—hematologic cancer	6.11e-05	0.000255	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CREBBP—hematologic cancer	6.11e-05	0.000255	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—HRAS—hematologic cancer	6.05e-05	0.000252	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—HRAS—hematologic cancer	6.05e-05	0.000252	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTP1—hematologic cancer	5.96e-05	0.000249	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTP1—hematologic cancer	5.96e-05	0.000249	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTP1—hematologic cancer	5.96e-05	0.000249	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—HRAS—hematologic cancer	5.93e-05	0.000247	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAP2K1—hematologic cancer	5.83e-05	0.000243	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAP2K1—hematologic cancer	5.83e-05	0.000243	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL1B—hematologic cancer	5.83e-05	0.000243	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—hematologic cancer	5.81e-05	0.000242	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—SRC—hematologic cancer	5.67e-05	0.000236	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—SRC—hematologic cancer	5.67e-05	0.000236	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTP1—hematologic cancer	5.65e-05	0.000236	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—JUN—hematologic cancer	5.65e-05	0.000236	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ABCB1—hematologic cancer	5.64e-05	0.000235	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCB1—hematologic cancer	5.64e-05	0.000235	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCB1—hematologic cancer	5.64e-05	0.000235	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—FGF2—hematologic cancer	5.54e-05	0.000231	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—FGF2—hematologic cancer	5.54e-05	0.000231	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—hematologic cancer	5.52e-05	0.00023	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—hematologic cancer	5.52e-05	0.00023	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTM1—hematologic cancer	5.47e-05	0.000228	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NCOR1—hematologic cancer	5.47e-05	0.000228	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NCOR1—hematologic cancer	5.47e-05	0.000228	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTM1—hematologic cancer	5.47e-05	0.000228	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTM1—hematologic cancer	5.47e-05	0.000228	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NCOR1—hematologic cancer	5.47e-05	0.000228	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—NRAS—hematologic cancer	5.45e-05	0.000227	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—NRAS—hematologic cancer	5.45e-05	0.000227	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—HRAS—hematologic cancer	5.36e-05	0.000224	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCB1—hematologic cancer	5.35e-05	0.000223	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—JAK2—hematologic cancer	5.31e-05	0.000222	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—JAK2—hematologic cancer	5.31e-05	0.000222	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—HRAS—hematologic cancer	5.29e-05	0.000221	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAPK3—hematologic cancer	5.22e-05	0.000218	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAPK3—hematologic cancer	5.22e-05	0.000218	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—EP300—hematologic cancer	5.21e-05	0.000217	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NCOR1—hematologic cancer	5.19e-05	0.000216	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTM1—hematologic cancer	5.19e-05	0.000216	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTP1—hematologic cancer	5.06e-05	0.000211	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTP1—hematologic cancer	4.99e-05	0.000208	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—hematologic cancer	4.93e-05	0.000206	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—CREB1—hematologic cancer	4.93e-05	0.000206	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—BRAF—hematologic cancer	4.87e-05	0.000203	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—MTHFR—hematologic cancer	4.84e-05	0.000202	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—MTHFR—hematologic cancer	4.84e-05	0.000202	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—MTHFR—hematologic cancer	4.84e-05	0.000202	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—hematologic cancer	4.69e-05	0.000196	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—hematologic cancer	4.69e-05	0.000196	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTM1—hematologic cancer	4.65e-05	0.000194	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTM1—hematologic cancer	4.59e-05	0.000191	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—MTHFR—hematologic cancer	4.59e-05	0.000191	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—HRAS—hematologic cancer	4.5e-05	0.000188	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—HRAS—hematologic cancer	4.5e-05	0.000188	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—hematologic cancer	4.23e-05	0.000176	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EP300—hematologic cancer	4.16e-05	0.000173	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EP300—hematologic cancer	4.16e-05	0.000173	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MDM2—hematologic cancer	4.08e-05	0.00017	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CG—hematologic cancer	4.07e-05	0.00017	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CG—hematologic cancer	4.07e-05	0.00017	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CG—hematologic cancer	4.07e-05	0.00017	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SRC—hematologic cancer	4.04e-05	0.000169	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SRC—hematologic cancer	4.04e-05	0.000169	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—HRAS—hematologic cancer	3.99e-05	0.000166	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—HRAS—hematologic cancer	3.99e-05	0.000166	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—hematologic cancer	3.94e-05	0.000164	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—hematologic cancer	3.94e-05	0.000164	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—STAT3—hematologic cancer	3.9e-05	0.000163	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—STAT3—hematologic cancer	3.9e-05	0.000163	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NRAS—hematologic cancer	3.89e-05	0.000162	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NRAS—hematologic cancer	3.89e-05	0.000162	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PHYH—hematologic cancer	3.88e-05	0.000162	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FTCD—hematologic cancer	3.88e-05	0.000162	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GMPS—hematologic cancer	3.88e-05	0.000162	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CG—hematologic cancer	3.85e-05	0.000161	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—hematologic cancer	3.82e-05	0.000159	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—hematologic cancer	3.82e-05	0.000159	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CREBBP—hematologic cancer	3.77e-05	0.000157	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CREBBP—hematologic cancer	3.77e-05	0.000157	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CREBBP—hematologic cancer	3.77e-05	0.000157	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK3—hematologic cancer	3.73e-05	0.000155	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK3—hematologic cancer	3.73e-05	0.000155	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TGFB1—hematologic cancer	3.62e-05	0.000151	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TGFB1—hematologic cancer	3.62e-05	0.000151	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CD—hematologic cancer	3.57e-05	0.000149	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CD—hematologic cancer	3.57e-05	0.000149	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CD—hematologic cancer	3.57e-05	0.000149	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CREBBP—hematologic cancer	3.57e-05	0.000149	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SMPD3—hematologic cancer	3.55e-05	0.000148	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALB—hematologic cancer	3.53e-05	0.000147	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALB—hematologic cancer	3.53e-05	0.000147	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALB—hematologic cancer	3.53e-05	0.000147	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—hematologic cancer	3.41e-05	0.000142	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CD—hematologic cancer	3.39e-05	0.000141	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—hematologic cancer	3.38e-05	0.000141	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—hematologic cancer	3.38e-05	0.000141	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3R1—hematologic cancer	3.37e-05	0.000141	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3R1—hematologic cancer	3.37e-05	0.000141	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3R1—hematologic cancer	3.37e-05	0.000141	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—hematologic cancer	3.35e-05	0.00014	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—hematologic cancer	3.35e-05	0.00014	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALB—hematologic cancer	3.34e-05	0.00014	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3R1—hematologic cancer	3.2e-05	0.000133	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CB—hematologic cancer	3.12e-05	0.00013	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CB—hematologic cancer	3.12e-05	0.00013	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CB—hematologic cancer	3.12e-05	0.00013	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—DCK—hematologic cancer	3.1e-05	0.000129	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—B3GAT1—hematologic cancer	3.1e-05	0.000129	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ASNS—hematologic cancer	3.1e-05	0.000129	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CB—hematologic cancer	2.95e-05	0.000123	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HDC—hematologic cancer	2.94e-05	0.000123	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HRAS—hematologic cancer	2.85e-05	0.000119	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HRAS—hematologic cancer	2.85e-05	0.000119	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—hematologic cancer	2.72e-05	0.000114	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—hematologic cancer	2.72e-05	0.000114	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTEN—hematologic cancer	2.69e-05	0.000112	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTEN—hematologic cancer	2.69e-05	0.000112	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTEN—hematologic cancer	2.69e-05	0.000112	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CDA—hematologic cancer	2.69e-05	0.000112	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PC—hematologic cancer	2.59e-05	0.000108	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—EP300—hematologic cancer	2.57e-05	0.000107	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—EP300—hematologic cancer	2.57e-05	0.000107	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—EP300—hematologic cancer	2.57e-05	0.000107	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTEN—hematologic cancer	2.55e-05	0.000106	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—hematologic cancer	2.51e-05	0.000105	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—hematologic cancer	2.51e-05	0.000105	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GBA—hematologic cancer	2.5e-05	0.000104	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC35B2—hematologic cancer	2.5e-05	0.000104	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—EP300—hematologic cancer	2.43e-05	0.000102	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTAP—hematologic cancer	2.29e-05	9.54e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—HRAS—hematologic cancer	2.24e-05	9.34e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—FHL2—hematologic cancer	2.04e-05	8.5e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AGRN—hematologic cancer	2e-05	8.33e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—hematologic cancer	1.9e-05	7.92e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—hematologic cancer	1.9e-05	7.92e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—hematologic cancer	1.9e-05	7.92e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HMMR—hematologic cancer	1.89e-05	7.9e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—IDH2—hematologic cancer	1.89e-05	7.9e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—hematologic cancer	1.8e-05	7.51e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ARNTL—hematologic cancer	1.78e-05	7.43e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ACP5—hematologic cancer	1.73e-05	7.23e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CA9—hematologic cancer	1.73e-05	7.23e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOR2—hematologic cancer	1.71e-05	7.13e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—IDH1—hematologic cancer	1.63e-05	6.79e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCC3—hematologic cancer	1.61e-05	6.72e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTO1—hematologic cancer	1.61e-05	6.72e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TXN—hematologic cancer	1.61e-05	6.72e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SPHK1—hematologic cancer	1.58e-05	6.57e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—hematologic cancer	1.55e-05	6.47e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—hematologic cancer	1.55e-05	6.47e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—hematologic cancer	1.55e-05	6.47e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UGT1A1—hematologic cancer	1.51e-05	6.32e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CRABP1—hematologic cancer	1.47e-05	6.14e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SLC22A1—hematologic cancer	1.47e-05	6.14e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—hematologic cancer	1.47e-05	6.13e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALOX5—hematologic cancer	1.44e-05	5.99e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NUP98—hematologic cancer	1.39e-05	5.8e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ADCY7—hematologic cancer	1.35e-05	5.63e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOA3—hematologic cancer	1.35e-05	5.63e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NUP214—hematologic cancer	1.34e-05	5.59e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTR—hematologic cancer	1.31e-05	5.48e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCG2—hematologic cancer	1.31e-05	5.48e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ENO2—hematologic cancer	1.29e-05	5.37e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTT1—hematologic cancer	1.25e-05	5.21e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SDC1—hematologic cancer	1.22e-05	5.09e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NQO1—hematologic cancer	1.04e-05	4.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CD44—hematologic cancer	1.04e-05	4.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYCS—hematologic cancer	9.82e-06	4.1e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSP90AA1—hematologic cancer	9.76e-06	4.07e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTP1—hematologic cancer	8.66e-06	3.61e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCB1—hematologic cancer	8.19e-06	3.42e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM1—hematologic cancer	7.95e-06	3.32e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOR1—hematologic cancer	7.95e-06	3.32e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTHFR—hematologic cancer	7.03e-06	2.93e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CG—hematologic cancer	5.91e-06	2.46e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CREBBP—hematologic cancer	5.48e-06	2.28e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CD—hematologic cancer	5.19e-06	2.17e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALB—hematologic cancer	5.13e-06	2.14e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3R1—hematologic cancer	4.9e-06	2.05e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CB—hematologic cancer	4.53e-06	1.89e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTEN—hematologic cancer	3.91e-06	1.63e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—EP300—hematologic cancer	3.73e-06	1.56e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—hematologic cancer	2.76e-06	1.15e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—hematologic cancer	2.25e-06	9.4e-06	CbGpPWpGaD
